Tong Jun Lin is listed as a director on 1 SEC Form D filing by 1 issuer in Jun 2009: China Biologic Products, Inc. (Tai'An City, Shandong, China (as filed: F4) — pharmaceuticals — 2009; $9.55M reported sold to 3 investors).
What this means One deal on file with the SEC, filed Jun 2009. A Form D is the notice a company files after it starts selling a private investment — it is a notice, not an approval.
Listed alongside Chao Ming Zhao (1 shared filing), Jie Gan (1 shared filing), Ling Lin Li (1 shared filing), Sean Shao (1 shared filing), Siu Ling Chan (1 shared filing) and 1 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Tong. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — 1 bankruptcy case matching the name listed in Key records below.
What this means 1 record came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.
We compared 1 public filing for Tong Jun Lin and found 1 difference: Form D filed 16 days after the first sale.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.